As of 2024-12-14, the Fair Value of Immunovant Inc (IMVT) is -11.00 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 26.28 USD, the upside of Immunovant Inc is -141.87%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 5Y Avg | |
| Net income | -66.39 | -107.43 | -156.73 | -210.96 | -259.34 | -183.61 |
| YoY growth | -% | -61.82% | -45.89% | -34.60% | -22.93% | -41.31% |
| Market Cap (mil) | 3,857.38 |
| P/E | |
| Forward P/E |
| EPS | -2.20 |
| Avg earnings growth rate | -41.31% |
| TTM earnings | -323.01 |